# IAM V1.5 — Prescribed Action Plan — Stop for Project Owner Review

| Field | Value |
| --- | --- |
| **Date** | 2026-07-23 |
| **Gate** | Product-completeness correction — Prescribed Action Plan |
| **Internal Validation** | **PAUSED** until PO acceptance |
| **Design Partner** | Not started |

## Why we stopped

IAM priorities quantified problems but did not prescribe corrective action. That gap is now addressed in code and documentation. Per instruction: **stop for Project Owner review before Internal Validation resumes.**

## What shipped (content only)

1. Required **Prescribed Action Plan** on every actionable Calculate priority  
2. Evidence-based **SKU / subgroup action groups** (not one generic action)  
3. **Location “0”** treated as invalid — company-level priority + data-quality warning  
4. Board card summary + Recommendation detail full plan  
5. Automated suite: `npm run test:prescribed-action-plan`  
6. Spec: [`docs/IAM_V1_5_Prescribed_Action_Plan.md`](./IAM_V1_5_Prescribed_Action_Plan.md)

## Explicitly unchanged

- Recommendation governance  
- Assignment / acceptance  
- Holdover  
- Lifecycle transitions  
- OEC  
- Executive Experience rules  

## PO decision needed

| Option | Meaning |
| --- | --- |
| **Accept** | Lift IV pause; authorize IT-01…IT-32 including PAP scenarios |
| **Revise** | Specify playbook / UX changes; remain paused |
| **Reject** | Revert or quarantine PAP content; remain paused |

**Do not resume Internal Validation scenario execution until PO records acceptance.**
